Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E, Clavio M, Raiola AM, Ghiso A, Guolo F, Minetto P, Galaverna F, Miglino M, Di Grazia C, Ballerini F, Marani C, Pastori G, Mitscheunig L, Cruciani F, Lovera D, Varaldo R, Ghiggi C, Lemoli RM, Bacigalupo A, Gobbi M. De Astis E, et al. Among authors: di grazia c. Ann Hematol. 2014 Dec;93(12):2011-8. doi: 10.1007/s00277-014-2143-8. Epub 2014 Jul 4. Ann Hematol. 2014. PMID: 24989345
Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin.
Lamparelli T, van Lint MT, Gualandi F, Raiola AM, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Bregante S, Berisso G, Dominietto A, Di Grazia C, Bruno B, Sessarego M, Casarino L, Verdiani S, Bacigalupo A. Lamparelli T, et al. Among authors: di grazia c. Bone Marrow Transplant. 2000 Dec;26(12):1305-11. doi: 10.1038/sj.bmt.1702719. Bone Marrow Transplant. 2000. PMID: 11223970
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation.
Dominietto A, Lamparelli T, Raiola AM, Van Lint MT, Gualandi F, Berisso G, Bregante S, Di Grazia C, Soracco M, Pitto A, Frassoni F, Bacigalupo A. Dominietto A, et al. Among authors: di grazia c. Blood. 2002 Dec 1;100(12):3930-4. doi: 10.1182/blood-2002-01-0339. Epub 2002 Aug 1. Blood. 2002. PMID: 12393584 Free article.
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
Miglino M, Berisso G, Grasso R, Canepa L, Clavio M, Pierri I, Pietrasanta D, Gatto S, Varaldo R, Ballerini F, Verdiani S, Casarino L, DeStefano F, Sessarego M, Dominietto A, Raiola AM, Bregante S, di Grazia C, Gobbi M, Bacigalupo A. Miglino M, et al. Among authors: di grazia c. Bone Marrow Transplant. 2002 Nov;30(9):579-85. doi: 10.1038/sj.bmt.1703659. Bone Marrow Transplant. 2002. PMID: 12407432
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.
Bacigalupo A, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C, Dominietto A, Bruno B, Galbusera V, Frassoni F, Podesta M, Tedone E, Occhini D, Van Lint MT. Bacigalupo A, et al. Among authors: di grazia c. Biol Blood Marrow Transplant. 2002;8(12):656-61. doi: 10.1053/bbmt.2002.v8.abbmt080656. Biol Blood Marrow Transplant. 2002. PMID: 12523577 Clinical Trial.
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.
Raiola AM, Van Lint MT, Valbonesi M, Lamparelli T, Gualandi F, Occhini D, Bregante S, di Grazia C, Dominietto A, Soracco M, Romagnani C, Vassallo F, Casini M, Bruno B, Frassoni F, Bacigalupo A. Raiola AM, et al. Among authors: di grazia c. Bone Marrow Transplant. 2003 Apr;31(8):687-93. doi: 10.1038/sj.bmt.1703883. Bone Marrow Transplant. 2003. PMID: 12692609
71 results